I do think the company is on the right path finally. Reality set in. My thinking is we have about bottomed out and continued sales will lift the pps slowly with a spike should many more states take a tougher stance on birth control by abortion. Or, to a degree larger should the law be codified. Otherwise, the sales increasing and the looming RS should about balance each other out. No one likes a RS, but where it is warranted it leads to positive longer term results as you know. Recently, I sold out on a RS in another pharmaceutical stock and didn't re-enter in time only to see some huge gains escape me. I believe the company too will be the target of a buyout. All things being equal, IMO, the sooner the better for the RS. Uncertain territory does nothing but drag down the pps. unless we were to see some monstrous increase in sales for a few quarters which I doubt will be the case. I will keep my toe wet, and jump back in post RS.
Market Data 
Markets 
AI
